{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:48:02Z","timestamp":1761630482620},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.clim.2008.02.011","type":"journal-article","created":{"date-parts":[[2008,4,10]],"date-time":"2008-04-10T18:08:40Z","timestamp":1207850920000},"page":"123-129","source":"Crossref","is-referenced-by-count":11,"title":["Focus on FOCIS: Interleukin 2 treatment associated autoimmunity"],"prefix":"10.1016","volume":"127","author":[{"given":"Stergios J.","family":"Moschos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maja","family":"Mandic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John M.","family":"Kirkwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter J.","family":"Storkus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael T.","family":"Lotze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clim.2008.02.011_bib1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/01.cmr.0000198452.03957.73","article-title":"Accumulation of low-avidity anti-melanocortin receptor 1 (anti-MC1R) CD8+ T cells in the lesional skin of a patient with melanoma-related depigmentation","volume":"16","author":"Wankowicz-Kalinska","year":"2006","journal-title":"Melanoma Res."},{"issue":"7","key":"10.1016\/j.clim.2008.02.011_bib2","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1200\/JCO.2005.03.6830","article-title":"Characterization of CD4+CD25+ regulatory T cells in patients treated with high-dose interleukin-2 for metastatic melanoma or renal cell carcinoma","volume":"24","author":"Cesana","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.clim.2008.02.011_bib3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1365-2567.2006.02550.x","article-title":"CD27 expression discriminates between regulatory and non-regulatory cells after expansion of human peripheral blood CD4+ CD25+ cells","volume":"121","author":"Duggleby","year":"2007","journal-title":"Immunology"},{"issue":"1\u20132","key":"10.1016\/j.clim.2008.02.011_bib4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jneuroim.2007.09.004","article-title":"High cell surface expression of CD4 allows distinction of CD4(+)CD25(+) antigen-specific effector T cells from CD4(+)CD25(+) regulatory T cells in murine experimental autoimmune encephalomyelitis","volume":"192","author":"Li","year":"2007","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.clim.2008.02.011_bib5","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1023\/B:JOCI.0000018067.71622.fb","article-title":"Immune response induced in vitro by CD16\u2212 and CD16+ monocyte-derived dendritic cells in patients with metastatic renal cell carcinoma treated with dendritic cell vaccines","volume":"24","author":"Arroyo","year":"2004","journal-title":"J. Clin. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2008.02.011_bib6","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2567.2007.02650.x","article-title":"Differential CD4(+) T-cell memory responses induced by two subsets of human monocyte-derived dendritic cells","volume":"122","author":"Bajana","year":"2007","journal-title":"Immunology."},{"issue":"4257","key":"10.1016\/j.clim.2008.02.011_bib7","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1126\/science.181845","article-title":"Selective in vitro growth of T lymphocytes from normal human bone marrows","volume":"193","author":"Morgan","year":"1976","journal-title":"Science"},{"issue":"11 Pt 1","key":"10.1016\/j.clim.2008.02.011_bib8","first-page":"4420","article-title":"Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor","volume":"41","author":"Lotze","year":"1981","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.clim.2008.02.011_bib9","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1084\/jem.161.5.1169","article-title":"Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2","volume":"161","author":"Rosenberg","year":"1985","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/j.clim.2008.02.011_bib10","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1200\/JCO.1999.17.7.2105","article-title":"High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993","volume":"17","author":"Atkins","year":"1999","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.clim.2008.02.011_bib11","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/pmic.200500004","article-title":"Inflammatory protein profile during systemic high dose interleukin-2 administration","volume":"6","author":"Rossi","year":"2006","journal-title":"Proteomics"},{"issue":"7","key":"10.1016\/j.clim.2008.02.011_bib12","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2002-3-7-research0035","article-title":"Gene-expression profiling of the response of peripheral blood mononuclear cells and melanoma metastases to systemic IL-2 administration","volume":"3","author":"Panelli","year":"2002","journal-title":"Genome Biol."},{"issue":"11","key":"10.1016\/j.clim.2008.02.011_bib13","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/ni1263","article-title":"A function for interleukin 2 in Foxp3-expressing regulatory T cells","volume":"6","author":"Fontenot","year":"2005","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.clim.2008.02.011_bib14","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1182\/blood-2005-06-2399","article-title":"IL-2 administration increases CD4+ CD25(hi) Foxp3+ regulatory T cells in cancer patients","volume":"107","author":"Ahmadzadeh","year":"2006","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.clim.2008.02.011_bib15","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJM198806163182401","article-title":"Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cells","volume":"318","author":"Atkins","year":"1988","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.clim.2008.02.011_bib16","first-page":"91","article-title":"The effect of interleukin-2 on suppressor T lymphocytes in autoimmune thyroid disease","volume":"18","author":"Yoshikawa","year":"1995","journal-title":"Clin. Invest. Med."},{"issue":"4","key":"10.1016\/j.clim.2008.02.011_bib17","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1600-0749.2005.00244.x","article-title":"Melanocyte-specific, cytotoxic T cell responses in vitiligo: the effective variant of melanoma immunity?","volume":"18","author":"Garbelli","year":"2005","journal-title":"Pigment Cell Res."},{"issue":"3","key":"10.1016\/j.clim.2008.02.011_bib18","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000247240","article-title":"Histocompatibility antigens in vitiligo: Hamburg study on 102 patients from northern Germany","volume":"187","author":"Schallreuter","year":"1993","journal-title":"Dermatology"},{"issue":"3","key":"10.1016\/j.clim.2008.02.011_bib19","first-page":"256","article-title":"Melanoma antigens recognised by CD8+ and CD4+ T cells","volume":"10","author":"Storkus","year":"2000","journal-title":"Forum (Genova)"},{"issue":"5","key":"10.1016\/j.clim.2008.02.011_bib20","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/01.LAB.0000069521.42488.1B","article-title":"Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligo","volume":"83","author":"Wankowicz-Kalinska","year":"2003","journal-title":"Lab. Invest."},{"issue":"9","key":"10.1016\/j.clim.2008.02.011_bib21","doi-asserted-by":"crossref","first-page":"5420","DOI":"10.4049\/jimmunol.172.9.5420","article-title":"Helper requirements for generation of effector CTL to islet beta cell antigens","volume":"172","author":"Behrens","year":"2004","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.clim.2008.02.011_bib22","doi-asserted-by":"crossref","first-page":"5255","DOI":"10.4049\/jimmunol.176.9.5255","article-title":"Interleukin-2-dependent mechanisms of tolerance and immunity in vivo","volume":"176","author":"Antony","year":"2006","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.clim.2008.02.011_bib23","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1084\/jem.190.8.1155","article-title":"Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)","volume":"190","author":"Fanger","year":"1999","journal-title":"J. Exp. Med."},{"issue":"25","key":"10.1016\/j.clim.2008.02.011_bib24","doi-asserted-by":"crossref","first-page":"6043","DOI":"10.1200\/JCO.2005.06.205","article-title":"Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4","volume":"23","author":"Attia","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.clim.2008.02.011_bib25","doi-asserted-by":"crossref","first-page":"7746","DOI":"10.4049\/jimmunol.175.11.7746","article-title":"Analysis of the cellular mechanism of antitumor responses and autoimmunity in patients treated with CTLA-4 blockade","volume":"175","author":"Maker","year":"2005","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.clim.2008.02.011_bib26","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.4049\/jimmunol.176.9.5136","article-title":"Comment on \"Analysis of the cellular mechanism of antitumor responses and autoimmunity in patients treated with CTLA-4 blockade\"","volume":"176","author":"O'Mahony","year":"2006","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.clim.2008.02.011_bib27","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00262-007-0407-z","article-title":"Impact of the CCR5 gene polymorphism on the survival of metastatic melanoma patients receiving immunotherapy","volume":"57","author":"Ugurel","year":"2008","journal-title":"Cancer Immunol. Immunother."},{"issue":"7","key":"10.1016\/j.clim.2008.02.011_bib28","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJMoa053007","article-title":"Prognostic significance of autoimmunity during treatment of melanoma with interferon","volume":"354","author":"Gogas","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.clim.2008.02.011_bib29","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa061592","article-title":"NALP1 in vitiligo-associated multiple autoimmune disease","volume":"356","author":"Jin","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2008.02.011_bib30","series-title":"DeVita, Hellman, and Rosenberg's Cancer: principles & practice of oncology","article-title":"Interleukin therapy [chapter 26.2]","author":"Lotze","year":"2008"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166160800065X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166160800065X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T03:21:11Z","timestamp":1557458471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152166160800065X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S152166160800065X"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2008.02.011","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}